10 бет - Израильде ең жақсы дәрігерлер — онлайн консультация алу

Dr. Ram (Rami) Palti is an orthopedic hand and upper limb surgeon. He has over 20 years of experience at the Hand Surgery Unit of Sheba Medical Center. He focuses on reconstructive surgery for congenital hand anomalies and deformity correction. He also performs complex microsurgery, nerve repair, and tendon reconstruction.

He earned his MD from Tel Aviv University. He completed an orthopedic residency at Sheba Medical Center. He completed fellowships in Upper Extremity Surgery at NYU Hospital for Joint Diseases and in Hand, Elbow and Peripheral Nerve Surgery at Royal North Shore Hospital. He also received advanced training in congenital upper limb surgery at Westmead Children’s Hospital.

He is a certified medical expert for the Israeli National Insurance Institute. He consults for the Israeli Ministry of Defense Rehabilitation Department and advises legal and government bodies. His practice emphasizes precise microsurgery with functional rehabilitation.

Дәрігер 33 жылдық тәжірибесі бар медициналық онколог және радиотерапевт, онкология және радиотерапия саласында маманданған. Ол Иерусалимдегі (Израиль) Хадасса университеттік ауруханасын бітірген және онкология мен радиотерапия саласында біліктілігі бар.<\/p>

Қазіргі уақытта ол Асқазан-ішек қатерлі ісік орталығының басшысы болып табылады, сондай-ақ Хадасса университеттік ауруханасының онкология бөлімінде аға дәрігер болып қызмет етеді. Ол онкология және радиотерапия саласындағы сертификаттау емтихандарын тапсырды және Израиль клиникалық онкология қоғамы мен Израиль қатерлі ісік қауымдастығы сияқты бірнеше кәсіби қоғамдардың мүшесі болып табылады.<\/p>

Дәрігер ересектер мен балалардағы омыртқа деформациялары, роботтандырылған омыртқа хирургиясы, омыртқааралық жарықтар, омыртқа ісіктері және омыртқа жарақаттары бойынша маманданған.<\/p>

Еврей университетін бітіріп, кардиология, жарақаттық реанимация және ортопедиялық травматология бойынша тереңдетілген дайындықтан өтті. Хадасса университеттік ауруханасында ортопедия бойынша резидентураны аяқтап, балалар вертебрологиясы бойынша қосымша дайындықтан өтті.<\/p>

Бронкс ауруханасында омыртқа хирургі болып жұмыс істеп, қазіргі уақытта Израильде күрделі омыртқа операциялары үшін роботтандырылған жабдықты пайдалана отырып жұмыс істейді. Ғылыми зерттеулермен, оқытумен айналысады және вертебрология бойынша көптеген мақалалар жариялады.<\/p>

Дәрігер Илизаров әдісін қолданып, аяқ-қолды ұзарту және қалпына келтіру операцияларына маманданған, аяқ-қол деформацияларын түзетуге және жарақаттан кейінгі жағдайларды емдеуге назар аударады. Сараптамаға хирургиялық және хирургиялық емес сыну емдері, буындарды сақтайтын артрит емдері және церебральды сал ауруына арналған ортопедиялық көмек кіреді. Дәрігер Иерусалимдегі Еврей университетін бітіріп, Хадасса медициналық орталығында ортопедия бойынша мамандандыруды аяқтады, Нью-Йорктегі Арнайы хирургия ауруханасында қосымша оқудан өтті. Медициналық білім беру мен зерттеулерге белсенді қатысады, белгілі ортопедиялық қоғамдардың мүшесі.<\/p>

Дәрігер әлемдегі ең үздік нейрохирургтардың бірі және Израильдегі жетекші омыртқа хирургі ретінде Израиль медициналық қауымдастығының мәліметі бойынша танылды. Ресей ұлттық зерттеу медицина университетін бітіргеннен кейін, дәрігер АҚШ, Швейцария, Франция, Италия және Австрияда өз біліктілігін арттырды.<\/p>

Хирургиялық және хирургиялық емес емдеу әдістеріне маманданған дәрігер, омыртқа аралық дискінің жарығы, сколиоз, диск аралық кеңістіктің тарылуы және нейрохирургиялық оңалтуға назар аударады, ересектер мен балалардағы омыртқа ауруларын емдеуде минималды инвазивті әдістерді қолданады. Ай сайын шамамен 60 операция жасай отырып, дәрігер Израиль ортопедиялық қауымдастығының, Израиль омыртқа қоғамының және Еуропа омыртқа қоғамының мүшесі болып табылады.<\/p>

Дәрігер Хадасса Еврей университеті ауруханасында 15 жылдан астам тәжірибесі бар көрнекті гематолог және сүйек кемігін трансплантациялау маманы. Ол Хадасса қоғамдық сүйек кемігі регистрі және Израильдің Ұлттық қан банкі медициналық директоры ретінде маңызды рөл атқарды. Дәрігер Милан университетінің медициналық дәрежесіне ие және Колорадо медициналық университетінде постдокторлық зерттеулерді аяқтады. Ол Иерусалимдегі Еврей университетінің доценті және медициналық журналдарда көптеген мақалалар жариялаған.

Дәрігер 2008 жылы Менахем Бегин сыйлығымен марапатталған және зерттеу зертханасын құрған. Қазіргі уақытта ол Хадасса Еврей университеті ауруханасында гематология, қатерлі ісік иммундық терапиясы, жасушалық терапия және сүйек кемігін трансплантациялау бөлімінің басшысы болып табылады.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Anton Wohl leads the Brain Tumors Unit at Sheba Medical Center (since 2026). He is a neurosurgeon specializing in neuro-oncology, brain tumor surgery, and stereotactic radiosurgery.

He performs complex tumor operations with intraoperative MRI and functional mapping. He also uses fluorescence guidance, neuronavigation, and awake craniotomy to help remove tumors safely and preserve function.

Accreditations: Israeli Board Certification in Neurosurgery; Israeli medical license; advanced international fellowships and training, including the Mayo Clinic (USA).

Research: author and co-author of peer-reviewed publications on glioblastoma, malignant brain tumors, radiosurgery, and experimental therapies.

Professor Pnina Langevich is a rheumatologist and immunologist with over 40 years of experience. She leads the National Center for Rheumatology and Autoimmune Diseases at Sheba Medical Center. Forbes Israel has repeatedly named her among the country’s top doctors.

She is an expert in rheumatoid arthritis, osteoarthritis, joint diseases, systemic lupus erythematosus, scleroderma, and complex autoimmune disorders. She treats severe, treatment‑resistant cases using advanced diagnostics and personalized therapy.

She trained in rheumatology and internal medicine at Sheba. She combines patient care with research on new therapies. She served for 12 years as Vice President of the World Association of Rheumatologists. She is Editor‑in‑Chief of Lupus and a member of the Israeli Medical Association and the International Association of Rheumatologists.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

RESEARCH ACTIVITY

1998–2000 — Conducted research on the genesis of cancer at The Royal Marsden Hospital (England).

PUBLICATIONS

Authored numerous peer-reviewed articles in scientific journals. Selected topics include:

Oncotype Dx Recurrence Score in BRCA1/2 germline mutation carriers with hormone receptor-positive breast cancer.

TP53 missense mutation recurrence in cancer patients of Arab descent.

Adjuvant autologous vaccine for stage III microscopic melanoma: biomarker survival and enhanced response to CTLA-4 blockade.

Prognostic significance of (R)CA15-3 assay in primary breast cancer.

Diagnostic and prognostic value of comparative thymidine kinase 1 (TK1) activity assays in breast cancer patient serum.

Complete remission in a BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma treated with cisplatin.

Autologous vaccine-induced antitumor and self-reactive immune responses in melanoma: impact on patient survival and dependence on MHC class II expression.

PROFESSIONAL AFFILIATIONS

Israeli Society of Clinical Oncology

Israel Medical Association

AWARDS & GRANTS

Cancer Genetics Research Foundation Award

Landau Prize

Judith Segal Memorial Award

Core Specializations

Oncology:

Head and neck tumors

Thyroid cancer

Personalized biological and immunotherapy

Treatment of recurrent cancer and spinal metastases

Radiotherapy

Education

1998 — Graduated from the Faculty of Medicine at the Hebrew University (Jerusalem, Israel).
2016 — Six-month advanced training course in radiosurgery with a special focus on modern methods of focused radiotherapy for spinal and malignant thyroid tumors at Memorial Sloan Kettering Cancer Center (New York, USA).

Professional Experience

1998–1999 — Internship at Hadassah University Hospital (Jerusalem, Israel).
1999–2005 — Specialization in the Department of Otolaryngology and Head & Neck Surgery at Rabin Medical Center (Petah Tikva, Israel).
2005–2009 — Specialization in oncology and radiotherapy at the Davidoff Cancer Center (Rabin Medical Center).
2006–2008 — Fellowship at the University of Michigan (Ann Arbor, USA) in multidisciplinary cancer treatment.
2008 — Fellowship in head and neck tumor brachytherapy at Beth Israel Medical Center (New York, USA).
2009–2012 — Head of the Head and Neck Oncology Clinic at the Davidoff Cancer Center.
2013–2019 — Chief of the Head and Neck Oncology Division and Deputy Head of the Radiotherapy Department at the Davidoff Cancer Center.
Since 2019 — Director of the Oncology Department and Sharett Cancer Institute at Hadassah University Hospital.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Dorit Zilberman, MD, is a Senior Urologist at Sheba Medical Center. She is a pioneer of robotic and minimally invasive urologic surgery in Israel with over 20 years of experience. Her work focuses on urologic oncology, robotic and laparoscopic surgery, and endourology. She helped launch the da Vinci robotic surgery program at Sheba. Her expertise includes kidney, bladder, and prostate cancers, as well as laser lithotripsy for stones.

She completed advanced training in robotic laparoscopic surgery and endourology at Duke University Medical Center. She is a Senior Clinical Lecturer at Tel Aviv University. She has authored more than 160 scientific publications. She has received awards from the Israeli and American Urological Associations. She was listed in Forbes Israel Best Doctors in 2024. She is a member of the Israeli, American, and European Urological Associations and the Endourological Society.